ID
15757
Description
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00131027
Link
https://clinicaltrials.gov/show/NCT00131027
Keywords
Versions (1)
- 6/11/16 6/11/16 -
Uploaded on
June 11, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphoblastic Leukemia, Acute NCT00131027
Eligibility Lymphoblastic Leukemia, Acute NCT00131027
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
active infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
life-threatening disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
hiv antibody
Data type
boolean
Alias
- UMLS CUI [1]
- C0019683
- UMLS CUI [2]
- C0019168
Description
another primary malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
pregnancy or breast-feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
history of renal failure
Data type
boolean
Alias
- UMLS CUI [1]
- C0035078
Similar models
Eligibility Lymphoblastic Leukemia, Acute NCT00131027
- StudyEvent: Eligibility
C1835417 (UMLS CUI [1,2])
C0600061 (UMLS CUI [2])
C0428772 (UMLS CUI [3])
C0019168 (UMLS CUI [2])
C0006147 (UMLS CUI [2])